183 related articles for article (PubMed ID: 37108661)
1. Evaluation of Some Safety Parameters of Dual Histamine H
Mika K; Szafarz M; Bednarski M; Siwek A; Szczepańska K; Kieć-Kononowicz K; Kotańska M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108661
[TBL] [Abstract][Full Text] [Related]
2. KSK-74: Dual Histamine H
Mika K; Szafarz M; Zadrożna M; Nowak B; Bednarski M; Szczepańska K; Pociecha K; Kubacka M; Nicosia N; Juda I; Kieć-Kononowicz K; Kotańska M
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806019
[TBL] [Abstract][Full Text] [Related]
3. Metabolic benefits of novel histamine H
Mika K; Szafarz M; Bednarski M; Kuder K; Szczepańska K; Pociecha K; Pomierny B; Kieć-Kononowicz K; Sapa J; Kotańska M
Biomed Pharmacother; 2021 Oct; 142():111952. PubMed ID: 34325303
[TBL] [Abstract][Full Text] [Related]
4. KSK19 - Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice.
Kotańska M; Mika K; Reguła K; Szczepańska K; Szafarz M; Bednarski M; Olejarz-Maciej A; Nowak K; Latacz G; Mogilski S; Kuder KJ; Kieć-Kononowicz K; Sapa J
Biochem Pharmacol; 2019 Oct; 168():193-203. PubMed ID: 31295465
[TBL] [Abstract][Full Text] [Related]
5. Histamine H
Mika K; Szafarz M; Bednarski M; Latacz G; Sudoł S; Handzlik J; Pociecha K; Knutelska J; Nicosia N; Szczepańska K; Kuder KJ; Kieć-Kononowicz K; Kotańska M
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832862
[TBL] [Abstract][Full Text] [Related]
6. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H
Szczepańska K; Podlewska S; Dichiara M; Gentile D; Patamia V; Rosier N; Mönnich D; Ruiz Cantero MC; Karcz T; Łażewska D; Siwek A; Pockes S; Cobos EJ; Marrazzo A; Stark H; Rescifina A; Bojarski AJ; Amata E; Kieć-Kononowicz K
ACS Chem Neurosci; 2022 Jan; 13(1):1-15. PubMed ID: 34908391
[TBL] [Abstract][Full Text] [Related]
7. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
Guryn R; Staszewski M; Kopczacki P; Walczyski K
Med Chem; 2016; 13(1):65-76. PubMed ID: 27220560
[TBL] [Abstract][Full Text] [Related]
8. Optimization and preclinical evaluation of novel histamine H
Szczepańska K; Karcz T; Kotańska M; Siwek A; Kuder KJ; Latacz G; Mogilski S; Hagenow S; Lubelska A; Sobolewski M; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2018 Dec; 26(23-24):6056-6066. PubMed ID: 30448256
[TBL] [Abstract][Full Text] [Related]
9. Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H
Riddy DM; Cook AE; Shackleford DM; Pierce TL; Mocaer E; Mannoury la Cour C; Sors A; Charman WN; Summers RJ; Sexton PM; Christopoulos A; Langmead CJ
Neuropharmacology; 2019 Jan; 144():244-255. PubMed ID: 30359639
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting Approach on Histamine H
Szczepańska K; Kuder KJ; Kieć-Kononowicz K
Curr Med Chem; 2021; 28(15):2974-2995. PubMed ID: 32767910
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of histamine H
Łażewska D; Kieć-Kononowicz K
Expert Opin Ther Pat; 2018 Mar; 28(3):175-196. PubMed ID: 29334795
[TBL] [Abstract][Full Text] [Related]
12. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.
Pérez-García C; Morales L; Cano MV; Sancho I; Alguacil LF
Psychopharmacology (Berl); 1999 Feb; 142(2):215-20. PubMed ID: 10102775
[TBL] [Abstract][Full Text] [Related]
13. Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.
de Lera Ruiz M; Zheng J; Berlin MY; McCormick KD; Aslanian RG; West R; Hwa J; Lachowicz J; van Heek M
Bioorg Med Chem Lett; 2013 Nov; 23(21):6004-9. PubMed ID: 24035485
[TBL] [Abstract][Full Text] [Related]
14. Using electrophysiology and in silico three-dimensional modeling to reduce human Ether-à-go-go related gene K(+) channel inhibition in a histamine H3 receptor antagonist program.
Davenport AJ; Möller C; Heifetz A; Mazanetz MP; Law RJ; Ebneth A; Gemkow MJ
Assay Drug Dev Technol; 2010 Dec; 8(6):781-9. PubMed ID: 21133680
[TBL] [Abstract][Full Text] [Related]
15. The discovery of quinoline based single-ligand human H
Procopiou PA; Ancliff RA; Gore PM; Hancock AP; Hodgson ST; Holmes DS; Keeling SP; Looker BE; Parr NA; Rowedder JE; Slack RJ
Bioorg Med Chem Lett; 2016 Dec; 26(24):5855-5859. PubMed ID: 27866818
[TBL] [Abstract][Full Text] [Related]
16. In silico and in vitro studies of two non-imidazole multiple targeting agents at histamine H
Ghamari N; Dastmalchi S; Zarei O; Arias-Montaño JA; Reiner D; Ustun-Alkan F; Stark H; Hamzeh-Mivehroud M
Chem Biol Drug Des; 2020 Feb; 95(2):279-290. PubMed ID: 31661597
[TBL] [Abstract][Full Text] [Related]
17. Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats.
Sadek B; Saad A; Latacz G; Kuder K; Olejarz A; Karcz T; Stark H; Kieć-Kononowicz K
Drug Des Devel Ther; 2016; 10():3879-3898. PubMed ID: 27932863
[TBL] [Abstract][Full Text] [Related]
18. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.
Molenhuis RT; Hutten L; Kas MJH
Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H
Szczepańska K; Karcz T; Mogilski S; Siwek A; Kuder KJ; Latacz G; Kubacka M; Hagenow S; Lubelska A; Olejarz A; Kotańska M; Sadek B; Stark H; Kieć-Kononowicz K
Eur J Med Chem; 2018 May; 152():223-234. PubMed ID: 29723785
[TBL] [Abstract][Full Text] [Related]
20. Histamine H3 receptor function and ligands: recent developments.
Singh M; Jadhav HR
Mini Rev Med Chem; 2013 Jan; 13(1):47-57. PubMed ID: 22931528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
